Compare EPAM Systems Inc (EPAM) vs SELLAS Life Sciences Group Inc. Common Stock (SLS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
EPAM Systems Inc vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? EPAM Systems Inc trades at $113.86 (market cap $5.59B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.27 (market cap $2.28B). The key difference: EPAM Systems Inc is far larger — about 2.5× SELLAS Life Sciences Group Inc. Common Stock's market cap, and SELLAS Life Sciences Group Inc. Common Stock is trading nearer its 52-week high, EPAM Systems Inc nearer its low. Which is the better fit depends on your goals.
| EPAM | SLS | |
|---|---|---|
Market Cap | $5.59B | $2.28B |
Volume | 551,846 | 3,128,960 |
Sector | Technology | Health |
52-Week High | $221.40 | $15.46 |
52-Week Low | $76.04 | $1.39 |
Typical Hold Time | 37 Days | — |
Enterprise Value | $4.95B | $2.15B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EPAM Systems trades at $108.32, down 0.91% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company reported Q2 2026 EPS of $3.38, beating estimates, and maintains strong profitability with a net margin of 7.15%. Recent news highlights partnerships in cloud security and AI-native revenue growth exceeding 11%.
The stock appears undervalued with a P/E of 14.7 and consensus price target of $119.00, offering potential upside. However, risks include slower North American growth and AI disruption to legacy services. Analyst sentiment is mixed with 59% buy ratings but recent institutional selling adds caution.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About EPAM Systems Inc
EPAM Systems Inc provides software product development and digital platform engineering services to clients located around the world. The company services include Software Product Development, Custom Application Development, Application Testing, Enterprise Application Platforms, Application Maintenance, and Support and Infrastructure Management. The company focuses on innovative and scalable software solutions. The company uses industry standard and custom developed technology, tools, and platforms to deliver results to handle business challenges. The company primarily offers its solutions in the following industries: financial services, travel and consumer, software and hi-tech, life sciences and healthcare. The majority of revenue is generated from North American clients.
Read more on EPAM →About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →
